Connect with us

Health

FDA proposes new regulatory framework on artificial intelligence, machine learning technologies – News-Medical.Net

The findings come from a cross-sectional study, published in BMJ Open, of the comments submitted to the US Food and Drug Administration (FDA) ‘Proposed Regulato…

Published

on

Reviewed by Emily Henderson, B.Sc.Oct 16 2020
The findings come from a cross-sectional study, published in BMJ Open, of the comments submitted to the US Food and Drug Administration (FDA) ‘Proposed Regulatory Framework for Modifications to Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD)–Discussion Paper and Request for Feedback’.
Artificial intelligence (AI) and machine learning (ML) technologies have the potential to transform health care, continual…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending